[HTML][HTML] Mechanisms of long COVID and the path toward therapeutics

MJ Peluso, SG Deeks - Cell, 2024 - cell.com
Long COVID, a type of post-acute sequelae of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2)(PASC) defined by medically unexplained symptoms following …

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

H Bonilla, MJ Peluso, K Rodgers, JA Aberg… - Frontiers in …, 2023 - frontiersin.org
Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide

J Savitz, WC Drevets - Neuroscience & Biobehavioral Reviews, 2009 - Elsevier
Both major depressive disorder and bipolar disorder are the subject of a voluminous
imaging and genetics literature. Here, we attempt a comprehensive review of MRI and …

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study

Ø Fluge, O Bruland, K Risa, A Storstein… - PloS one, 2011 - journals.plos.org
Background Chronic fatigue syndrome (CFS) is a disease of unknown aetiology. Major CFS
symptom relief during cancer chemotherapy in a patient with synchronous CFS and …

Chronic fatigue syndrome, the immune system and viral infection

AS Bansal, AS Bradley, KN Bishop… - Brain, behavior, and …, 2012 - Elsevier
The chronic fatigue syndrome (CFS), as defined by recent criteria, is a heterogeneous
disorder with a common set of symptoms that often either follows a viral infection or a period …

Chronic fatigue syndrome: diagnosis and treatment

JR Yancey, SM Thomas - American family physician, 2012 - aafp.org
Chronic fatigue syndrome is characterized by debilitating fatigue that is not relieved with rest
and is associated with physical symptoms. The Centers for Disease Control and Prevention …

[HTML][HTML] Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?

M Ruiz-Pablos, B Paiva, A Zabaleta - Journal of Translational Medicine, 2023 - Springer
Both myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) and long COVID
(LC) are characterized by similar immunological alterations, persistence of chronic viral …

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26

MA Fletcher, XR Zeng, K Maher, S Levis, B Hurwitz… - PloS one, 2010 - journals.plos.org
Background Chronic Fatigue Syndrome (CFS) studies from our laboratory and others
described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of …

Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions

NG Klimas, AOB Koneru - Current rheumatology reports, 2007 - Springer
Investigations into the underlying cause of chronic fatigue syndrome have advanced the
field considerably in the past year. Gene microarray data have led to a better understanding …

[HTML][HTML] Low-dose naltrexone as a treatment for chronic fatigue syndrome

MJ Bolton, BP Chapman… - BMJ Case Reports …, 2020 - casereports.bmj.com
Naltrexone is used as an off-label treatment in low doses for several chronic immune-
modulated disorders in many countries. Although only small-scale clinical trials have been …